Examkin

Question

Difficulty: MediumHemodynamic and Coagulation Processes

Evaluate the following four patient scenarios presenting with hematologic and coagulation abnormalities. For each clinical presentation, select the most accurate underlying pathophysiologic mechanism driving the disease process.

  • A 28-year-old primigravida at 34 weeks gestation with right upper quadrant pain, elevated transaminases, schistocytes, and a platelet count of 65,000/mcL with normal PT and aPTT.Endothelial dysfunction and hepatic sinusoid fibrin deposition driven by abnormal placentation, lacking systemic coagulation factor consumption.
  • A 32-year-old woman with systemic lupus erythematosus exhibiting new-onset confusion, fever, schistocytes, and a platelet count of 18,000/mcL with normal PT and aPTT.Autoantibody-mediated inhibition of ADAMTS13 metalloprotease, resulting in the accumulation of ultra-large von Willebrand factor multimers.
  • A 45-year-old man undergoing induction chemotherapy for acute promyelocytic leukemia with diffuse mucosal oozing, hypofibrinogenemia, elevated D-dimer, and prolonged PT and aPTT.Widespread systemic activation of the coagulation cascade causing microvascular thrombosis and profound depletion of clotting factors.
  • A 6-year-old child with pale skin, oliguria, and petechiae following a bout of bloody diarrhea, presenting with schistocytes and a platelet count of 45,000/mcL with normal PT and aPTT.Exotoxin-mediated endothelial damage predominantly within the renal microvasculature, leading to localized platelet activation and microthrombi.

Answer

HELLP syndrome is paired with abnormal placentation; TTP is paired with ADAMTS13 inhibition; DIC is paired with systemic coagulation activation; and HUS is paired with exotoxin-mediated damage.
The correct matches effectively differentiate the primary microangiopathic hemolytic anemias (MAHA) and consumptive coagulopathies. HELLP syndrome is specific to pregnancy and driven by abnormal placentation resulting in hepatic sinusoid fibrin deposition. TTP is caused by ADAMTS13 deficiency, often due to autoantibodies in patients with autoimmune diseases like SLE, which prevents the cleavage of large von Willebrand factor multimers. DIC involves the widespread activation of the coagulation cascade, depleting both platelets and clotting factors (resulting in prolonged PT/aPTT), often triggered by the release of procoagulants in states like acute promyelocytic leukemia. HUS is characterized by Shiga exotoxin-mediated endothelial injury, predominantly affecting the kidneys after a diarrheal illness.

Step-by-Step Solution

1
Analyze the coagulation profile for each patient to differentiate between disorders of primary hemostasis or isolated microangiopathy and secondary hemostatic consumptive disorders.
Patients 1, 2, and 4 have normal PT/aPTT, indicating primary hemostatic or localized microangiopathic processes. Patient 3 has prolonged PT/aPTT, indicating a widespread consumptive coagulopathy.
Normal PT and aPTT effectively rule out DIC and point towards TTP, HUS, or HELLP syndrome, as these primarily consume platelets rather than systemic clotting factors.
2
Identify the distinct clinical triggers and presentations for the patients with normal PT/aPTT.
Patient 1 is in the third trimester of pregnancy with liver involvement (HELLP). Patient 2 has SLE and prominent neurologic symptoms (TTP). Patient 4 is a child presenting with post-diarrheal renal failure (HUS).
Because the laboratory features of microangiopathic hemolytic anemias overlap heavily, the clinical context is essential to separate them.
3
Match the identified conditions with their specific underlying pathophysiologic mechanisms.
HELLP matches abnormal placentation. TTP matches ADAMTS13 inhibition. DIC matches systemic coagulation activation. HUS matches Shiga exotoxin damage.
Linking the clinical syndrome directly to its molecular and hemodynamic driver solidifies the final answer.

Key Concept

Differentiation of microangiopathic hemolytic anemias and consumptive coagulopathies based on clinical context and coagulation cascade parameters.
Rate this question

Topics

Hemodynamic and Coagulation Processes

More questions from this topic